Dare Bioscience (DARE) Misses Q1 EPS by 50c

Dare Bioscience (NASDAQ: DARE) reported Q1 EPS of ($0.50). Revenue for the quarter came in at $25.42 million.

For earnings history and earnings-related data on Dare Bioscience (DARE) click here.

You May Also Be Interested In

• Assurant (AIZ) is Piper Sandler's Weekly Focus Idea
• Sandisk (SNDK) call put ratio 1 call to 1.3 puts a focus on June 26 weekly puts as share price up 6%
• Increasing unusual call volume: GDS CRDF COLO AIG ERAS BFLY TIMI OTLK SGOL HELP CRS